These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biotech marks time in Q3. Lawrence S Nat Biotechnol; 2005 Nov; 23(11):1332. PubMed ID: 16273049 [No Abstract] [Full Text] [Related]
4. The rise of European venture capital for biotechnology. Howell M; Trull M; Dibner MD Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356 [No Abstract] [Full Text] [Related]
5. Putting a price on biotechnology. Stewart JJ; Allison PN; Johnson RS Nat Biotechnol; 2001 Sep; 19(9):813-7. PubMed ID: 11533634 [No Abstract] [Full Text] [Related]
7. Eli Lilly enters venture capital arena. Fletcher L Nat Biotechnol; 2001 Nov; 19(11):997-8. PubMed ID: 11689830 [No Abstract] [Full Text] [Related]
8. Consolidations in biotechnology. Persidis A Nat Biotechnol; 1999 Feb; 17 Suppl():BE3-4. PubMed ID: 10052311 [No Abstract] [Full Text] [Related]
9. Biotechnology financing dilemmas and the role of special purpose entities. Schiff L; Murray F Nat Biotechnol; 2004 Mar; 22(3):271-7. PubMed ID: 14990945 [No Abstract] [Full Text] [Related]